Last Price
1.80
Today's Change
-0.40 (18.18%)
Day's Change
1.75 - 2.19
Trading Volume
645,790
Market Cap
2 Million
Shares Outstanding
1 Million
Avg Volume
637,509
Avg Price (50 Days)
7.55
Avg Price (200 Days)
78.18
PE Ratio
-0.09
EPS
-20.40
Earnings Announcement
18-Nov-2024
Previous Close
2.20
Open
2.18
Day's Range
1.75 - 2.1901
Year Range
1.75 - 392.0
Trading Volume
645,790
1 Day Change
-18.18%
5 Day Change
-34.31%
1 Month Change
-74.72%
3 Month Change
-81.73%
6 Month Change
-91.04%
Ytd Change
-76.22%
1 Year Change
-99.26%
3 Year Change
-99.82%
5 Year Change
-99.82%
10 Year Change
-99.82%
Max Change
-99.82%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.